19th Dec 2018 18:28
Renalytix AI plc
("RenalytixAI" or the "Company")
Director Dealing
The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.
Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.
Enquiries:
Renalytix AI plc | www.renalytixai.com |
James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 |
N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / James White / George Tzimas (Corporate Finance) | |
Tom Salvesen / Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 |
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Harwood Capital LLP (Harwood) as investment manager to NASCIT
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT) | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Renalytix AI Plc | |||
b)
| LEI
| 213800NTOH3FK3WER551 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.25 pence each
| |||
Identification code | GB00BYWL4Y04 | ||||
| |||||
b)
| Nature of the transaction
| Purchase of shares | |||
c)
| Price(s) and volume(s) |
|
|
|
|
| Price(s) | Volume(s) |
| ||
| 103 pence | 5,970 |
| ||
|
|
|
| ||
d)
| Aggregated information | N/A | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 December 2018 | |||
f)
| Place of the transaction
| London Stock Exchange | |||
Related Shares:
Renalytix Plc